Melanoma is the deadliest skin cancer with yearly increasing incidence and poor prognosis due to failure ofboth primary and secondary prevention strategies, respectively. Melanoma treatment strategies are oftenunsuccessful due to patients? intrinsic or acquired drug resistance, highlighting the need for novel, secondaryprevention-intervention strategies with thoroughly validated mechanistic targets. Therefore, my career goal isto become an independent, academic melanoma researcher, with a focus in translational science to developstrategies to target melanoma.
